| Title | Authors | Journal | Year | Volume | Issue | Beginning Page | |
|---|---|---|---|---|---|---|---|
| 1 | Monitoring cytokine profiles during immunotherapy | Siebert, Janet C.; Walker, Edwin B. | IMMUNOTHERAPY | 2010 | 2 | 6 | 799 |
| 2 | Equivalence of ELISpot Assays Demonstrated between Major HIV Network Laboratories | Gill, Dilbinder K.; Huang, Yunda; Levine, Gail L.; et al. | PLOS ONE | 2010 | 5 | 12 | |
| 3 | MHC-peptide tetramers for the analysis of antigen-specific T cells | Sims, Stuart; Willberg, Christian; Klenerman, Paul | EXPERT REVIEW OF VACCINES | 2010 | 9 | 7 | 765 |
| 4 | T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays | Martin, Stefan F.; Esser, Philipp R.; Schmucker, Sonja et al. | CELLULAR AND MOLECULAR LIFE SCIENCES | 2010 | 67 | 24 | 4171 |
| 5 | Dendritic Cells Are They Clinically Relevant? | Palucka, Karolina; Ueno, Hideki; Roberts, Lee; Fay, Joseph; Banchereau, Jacques | CANCER JOURNAL | 2010 | 16 | 4 | 318 |
| 6 | Overcoming the hurdles of randomised clinical trials of therapeutic cancer vaccines | Sasada, Tetsuro; Komatsu, Nobukazu; Suekane, Shigetaka; Yamada, Akira; Noguchi, Masanori; Itoh, Kyogo | EUROPEAN JOURNAL OF CANCER | 2010 | 46 | 9 | 1514 |
| 7 | Development and application of 'phosphoflow' as a tool for immunomonitoring | Wu, Sheng; Jin, Lei; Vence, Luis; Radvanyi, Laszlo G. | EXPERT REVIEW OF VACCINES | 2010 | 9 | 6 | 631 |
| 8 | Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference | Wahren, Britta; Biswas, Priscilla; Borggren, Marie et al. | JOURNAL OF TRANSLATIONAL MEDICINE | 2010 | 8 | ||
| 9 | Improved Endpoints for Cancer Immunotherapy Trials | Hoos, Axel; Eggermont, Alexander M. M.; Janetzki, Sylvia; Hodi, F. Stephen; Ibrahim, Ramy; Anderson, Aparna; Humphrey, Rachel; Blumenstein, Brent; Old, Lloyd; Wolchok, Jedd | JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2010 | 102 | 18 | 1388 |
| 10 | DNA vaccines against cancer come of age | Stevenson, Freda K.; Ottensmeier, Christian H.; Rice, Jason | CURRENT OPINION IN IMMUNOLOGY | 2010 | 22 | 2 | 264 |
| 11 | Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes | Roep, Bart O.; Peakman, Mark | NATURE REVIEWS IMMUNOLOGY | 2010 | 10 | 2 | 145 |
| 12 | Response definition criteria for ELISPOT assays revisited | Moodie, Z.; Price, L.; Gouttefangeas, C.; Mander, A.; Janetzki, S.; Loewer, M.; Welters, M. J. P.; Ottensmeier, C.; van der Burg, S. H.; Britten, Cedrik M. | CANCER IMMUNOLOGY IMMUNOTHERAPY | 2010 | 59 | 10 | 1489 |
| 13 | A model for harmonizing flow cytometry in clinical trials | Maecker, Holden T.; McCoy, J. Philip, Jr. | NATURE IMMUNOLOGY | 2010 | 11 | 11 | 975 |
| 14 | Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity | Speiser, Daniel E.; Romero, Pedro | SEMINARS IN IMMUNOLOGY | 2010 | 22 | 3 | 144 |
| 15 | An integrative paradigm to impart quality to correlative science | Kalos, Michael | JOURNAL OF TRANSLATIONAL MEDICINE | 2010 | 8 | ||
| 16 | Serum is not required for ex vivo IFN-gamma ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program | Mander, A.; Gouttefangeas, C.; Ottensmeier, C.; Welters, M. J. P.; Low, L.; van der Burg, S. H.; Britten, C. M. | CANCER IMMUNOLOGY IMMUNOTHERAPY | 2010 | 59 | 4 | 619 |
| 17 | Evaluation of cellular immune responses in cancer vaccine recipients: lessons from NY-ESO-1 | Cebon, Jonathan; Knights, Ashley; Ebert, Lisa; Jackson, Heather; Chen, Weisan | EXPERT REVIEW OF VACCINES | 2010 | 9 | 6 | 617 |
| 18 | Critical parameters in blood processing for T-cell assays: Validation on ELISpot and tetramer platforms | Afonso, Georgia; Scotto, Matthieu; Renand, Amedee; Arvastsson, Jeanette; Vassilieff, Dominique; Cilio, Corrado M.; Mallone, Roberto | JOURNAL OF IMMUNOLOGICAL METHODS | 2010 | 359 | 1-2 | 28 |
| 19 | New approaches to design HIV-1 T-cell vaccines | Perrin, Helene; Canderan, Glenda; Sekaly, Rafick-Pierre; Trautmann, Lydie | CURRENT OPINION IN HIV AND AIDS | 2010 | 5 | 5 | 368 |
| 20 | Meeting Report from the Second "Minimum Information for Biological and Biomedical Investigations" (MIBBI) workshop. | Kettner C, Field D, Sansone SA, et al. | STAND GENOMIC SCI | 2010 | 3 | 3 | 259 |
| 21 | Dendritic cells in cancer immunotherapy | Schuler G | EUROPEAN JOURNAL OF IMMUNOLOGY | 2010 | 40 | 8 | 2123 |
| 22 | Phase I Trial of a Personalized Peptide Vaccine for Patients Positive for Human Leukocyte Antigen-A24 With Recurrent or Progressive Glioblastoma Multiforme | Terasaki, Mizuhiko; Shibui, Soichiro; Narita, Yoshitaka; Fujimaki, Takamitsu; Aoki, Tomokazu; Kajiwara, Koji; Sawamura, Yutaka; Kurisu, Kaoru; Mineta, Toshihiro; Yamada, Akira; Itoh, Kyogo | JOURNAL OF CLINICAL ONCOLOGY | 2011 | 29 | 3 | 337 |
| 23 | Strength of TCR-Peptide/MHC Interactions and In Vivo T Cell Responses | Corse, Emily; Gottschalk, Rachel A.; Allison, James P. | JOURNAL OF IMMUNOLOGY | 2011 | 186 | 9 | 5039 |
| 24 | Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond | Britten, C. M.; Janetzki, S.; van der Burg, S. H.; Huber, C.; Kalos, M.; Levitsky, H. I.; Maecker, H. T.; Melief, C. J. M.; O'Donnell-Tormey, J.; Odunsi, K.; Old, L. J.; Pawelec, G.; Roep, B. O.; Romero, P.; Hoos, A.; Davis, M. M. | CANCER IMMUNOLOGY IMMUNOTHERAPY | 2011 | 60 | 1 | 15 |
| 25 | Dendritic Cell Subsets as Vectors and Targets for Improved Cancer Therapy | Palucka, Karolina; Ueno, Hideki; Roberts, Lee; Fay, Joseph; Banchereau, Jacques | CANCER IMMUNOLOGY AND IMMUNOTHERAPY | 2011 | 344 | 173 | |
| 26 | Sources of diversity in T cell epitope discovery | Chang, Cynthia Xin Lei; Dai, Lingyun; Tan, Zhen Wei; Choo, Joanna Ai Ling; Bertoletti, Antonio; Grotenbreg, Gijsbert M. | FRONTIERS IN BIOSCIENCE-LANDMARK | 2011 | 16 | 3014 | |
| 27 | A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols | Attig, Sebastian; Price, Leah; Janetzki, Sylvia; Kalos, Michael; Pride, Michael; McNeil, Lisa; Clay, Tim; Yuan, Jianda; Odunsi, Kunle; Hoos, Axel; Romero, Pedro; Britten, Cedrik M. | JOURNAL OF TRANSLATIONAL MEDICINE | 2011 | 9 | ||
| 28 | Interrogating the repertoire: broadening the scope of peptide-MHC multimer analysis | Davis, Mark M.; Altman, John D.; Newell, Evan W. | NATURE REVIEWS IMMUNOLOGY | 2011 | 11 | 8 | 551 |
| 29 | Cancer immunotherapy - revisited | Lesterhuis, W. Joost; Haanen, John B. A. G.; Punt, Cornelis J. A. | NATURE REVIEWS DRUG DISCOVERY | 2011 | 10 | 8 | 591 |
| 30 | Melanoma vaccines: developments over the past 10 years | Klein, Oliver; Schmidt, Christopher; Knights, Ashley; Davis, Ian D; Chen, Weisan; Cebon, Jonathan | EXPERT REVIEWS OF VACCINES | 2011 | 10 | 6 | 853 |
| 31 | Therapeutic cancer vaccines: are we there yet? | Klebanoff, Christopher A.; Acquavella, Nicolas; Yu, Zhiya; Restifo, Nicholas P. | IMMUNOLOGICAL REVIEWS | 2011 | 239 | 27 | |
| 32 | Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society | Mallone, R.; Mannering, S. I.; Brooks-Worrell, B. M.; Durinovic-Bello, I.; Cilio, C. M.; Wong, F. S.; Schloot, N. C. | CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2011 | 163 | 1 | 33 |
| 33 | Biomarkers in T cell therapy clinical trials. | Kalos M. | JOURNAL OF TRANSLATIONAL MEDICINE | 2011 | 9 | 138 | |
| 34 | Upfront immunization with autologous recombinant idiotype Fab fragment without prior cytoreduction in indolent B-cell lymphoma | Navarrete, Marcelo A.; Heining-Mikesch, Kristina; Schueler, Frank; Bertinetti-Lapatki, Cristina; Ihorst, Gabriele; Keppler-Hafkemeyer, Andrea; Doelken, Gottfried; Veelken, Hendrik | BLOOD | 2011 | 117 | 5 | 1483 |
| 35 | Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers | Butterfield, Lisa H.; Palucka, A. Karolina; Britten, Cedrik M. et al. | CLINICAL CANCER RESEARCH | 2011 | 17 | 10 | 3064 |
| 36 | T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia | Kalos, Michael; Levine, Bruce L.; Porter, David L.; Katz, Sharyn; Grupp, Stephan A.; Bagg, Adam; June, Carl H. | SCIENCE TRANSLATIONAL MEDICINE | 2011 | 3 | 95 | |
| 37 | Evaluation of current cancer immunotherapy: hemato-oncology. | Hourigan CS, Levitsky HI. | CANCER JOURNAL | 2011 | 17 | 5 | 309 |
| 38 | Dendritic cell vaccines in cancer immunotherapy: from biology to translational medicine | Xu H, Cao X | FRONTIERS OF MEDICINE | 2011 | 5 | 4 | 323 |
| 39 | A methodological framework to enhance the clinical success of cancer immunotherapy | Hoos, Axel; Britten, Cedrik M.; Huber, Christoph; O'Donnell-Tormey, Jill | NATURE BIOTECHNOLOGY | 2011 | 29 | 10 | 867 |
| 40 | Harmonization of immune biomarker assays for clinical studies. | van der Burg SH, Kalos M, Gouttefangeas C, Janetzki S, Ottensmeier C, Welters MJ, Romero P, Britten CM, Hoos A. | SCIENCE TRANSLATIONAL MEDICINE | 2011 | 3 | 108 | |
| 41 | The impact of harmonization on ELISPOT assay performance. | Janetzki S, Britten CM | METHODS MOL BIOL. | 2012 | 792 | 25 | |
| 42 | Response determination criteria for ELISPOT: toward a standard that can be applied across laboratories. | Moodie Z, Price L, Janetzki S, Britten CM. | METHODS MOL BIOL. | 2012 | 792 | 185 | |
| 43 | Defining the Critical Hurdles in Cancer Immunotherapy | Fox BA, Schendel DJ, Butterfield LH, et al. | JOURNAL OF TRANSLATIONAL MEDICINE | 2011 | 9 | 214 | |
| 44 | Objective, user-independent ELISPOT data analysis based on scientifically validated principles | Zhang W, Lehmann PV | METHODS MOL BIOL. | 2012 | 792 | 155 | |
| 45 | New concepts for building vocabulary for cell image ontologies. | Plant AL, Elliott JT, Bhat TN. | BMC BIOINFORMATICS | 2011 | 12 | 487 | |
| 46 | Novel cancer immunotherapy agents with survival benefit: recent successes and next steps | Sharma P, Wagner K, Wolchok JD, and Allison JP | NATURE REVIEWS CANCER | 2011 | 11 | 805 | |
| 47 | The immuno-oncology framework: Enabling a new era of cancer therapy | Hoos A, Britten CM | ONCOIMMUNOLOGY | 2012 | 1 | 3 | 1 |
| 48 | Design of therapeutic vaccines: hepatitis B as an example | Kutscher, S; Bauer, T; Dembek, C; Sprinzl, M; Protzer, U | MICROBIAL BIOTECHNOLOGY | 2012 | 5 | 2 | 270 |
| 49 | Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons | Wald, A; Koelle, DM; Fife, K; Warren, T; LeClair, K; Chicz, RM; Monks, S; Levey, DL; Musselli, C; Srivastava, PK | VACCINE | 2011 | 29 | 47 | 8520 |
| 50 | The Stanford Data Miner: a novel approach for integrating and exploring heterogeneous immunological data | Siebert JC, Munsil W, Rosenberg-Hasson Y, Davis MM, Maecker HT | JOURNAL OF TRANSLATIONAL MEDICINE | 2012 | 10 | 62 | |
| 51 | Harmonization of the intracellular cytokine staining assay | Welters, MJP; Gouttefangeas, C; Ramwadhdoebe, TH; Letsch, A; Ottensmeier, CH; Britten, CM; van der Burg, SH | CANCER IMMUNOLOGY IMMUNOTHERAPY | 2012 | 61 | 7 | 967 |
| 52 | The simultaneous ex vivo detection of low-frequency antigen-specific CD4+ and CD8+ T-cell responses using overlapping peptide pools. | Singh SK, Meyering M, Ramwadhdoebe TH, Stynenbosch LF, Redeker A, Kuppen PJ, Melief CJ,Welters MJ, van der Burg SH | CANCER IMMUNOLOGY IMMUNOTHERAPY | 2012 | |||
| 53 | DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8(+) T-cell responses and increases PSA doubling time. | Chudley L, McCann K, Mander A, Tjelle T, Campos-Perez J, Godeseth R, Creak A, Dobbyn J, Johnson B, Bass P, Heath C, Kerr P, Mathiesen I, Dearnaley D, Stevenson F, Ottensmeier C | CANCER IMMUNOLOGY IMMUNOTHERAPY | 2012 | |||
| 54 | Immune Monitoring Design within the Developmental Pipeline for an Immunotherapeutic or Preventive Vaccine | Janetzki S, Romero P, Roederer M, Bolton DL, Jandus C. | VACCINOLOGY: PRINCIPLES AND PRACTICE. Edited by W. John W. Morrow, Nadeem A. Sheikh, Clint S. Schmidt, D. Huw Davies | 2012 | Chapter 28 | 419 | |
| 55 | Distinguishing Latent from Active Mycobacterium tuberculosis Infection Using Elispot Assays: Looking Beyond Interferon-gamma | Camilla Tincati 1, Amedeo J. Cappione III 2 and Jennifer E. Snyder-Cappione | CELLS | 2012 | 1 | 2 | 89 |
| 56 | Adjunct immunotherapies for tuberculosis | Uhlin M, Andersson J, Zumla A, Maeurer M | JOURNAL OF INFECTIOUS DISEASES | 2012 | 205 | 325 | |
| 57 | T Cell Assays and MIATA: The Essential Minimum for Maximum Impact. | Britten CM, Janetzki S, Butterfield LH, Ferrari G, Gouttefangeas C, Huber C, Kalos M, Levitsky HI, Maecker HT, Melief CJ, O'Donnell-Tormey J, Odunsi K, Old LJ, Ottenhoff TH, Ottensmeier C, Pawelec G, Roederer M, Roep BO, Romero P, van der Burg SH, Walter S, Hoos A, Davis MM. | IMMUNITY | 2012 | 27 | 37 | 1 |
| 58 | Advancing the field of cancer immunotherapy: MIATA consensus guidelines become available to improve data reporting and interpretation for T-cell immune monitoring. | Hoos A, Janetzki S, Britten CM. | ONCOIMMUNOLOGY | 2012 | 1 | 9 | 1457 |
| 59 | Trial watch: Peptide vaccines in cancer therapy. | Vacchelli E, Martins I, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. | ONCOIMMUNOLOGY | 2012 | 1 | 9 | 1557 |
| 60 | A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions | van Steenwijk, Peggy J. de Vos; Ramwadhdoebe, Tamara H.; Lowik, Margriet J. G.; et al. | CANCER IMMUNOLOGY IMMUNOTHERAPY | 2012 | 61 | 9 | 1485 |
| 61 | Flow Cytometry | Jahan-Tigh, Richard R.; Ryan, Caitriona; Obermoser, Gerlinde; et al. | JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2012 | 132 | 10 | 1 |
| 62 | Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters | Aarntzen, Erik H. J. G.; de Vries, I. Jolanda M.; Goertz, Joop H.; et al. | CANCER IMMUNOLOGY IMMUNOTHERAPY | 2012 | 61 | 11 | 2003 |
| 63 | Addition of interferon-alpha to the p53-SLP (R) vaccine results in increased production of interferon-gamma in vaccinated colorectal cancer patients: A phase I/II clinical trial | Zeestraten, Eliane C. M.; Speetjens, Frank M.; Welters, Marij J. P.; et al. | INTERNATIONAL JOURNAL OF CANCER | 2013 | 132 | 7 | 1581 |
| 64 | Biomarkers for immunostimulatory monoclonal antibodies in combination strategies for melanoma and other tumor types | Ascierto PA, Kalos M, Schaer DA, Callahan MK, Wolchok JD | CLINICAL CANCER RESEARCH | 2013 | 19 | 5 | 1005 |
| 65 | The development of standard samples with a defined number of antigen-specific T cells to harmonize T cell assays: a proof-of-principle study. | Singh SK, Tummers B, Schumacher TN, Gomez R, Franken KL, Verdegaal EM, Laske K, Gouttefangeas C, Ottensmeier C, Welters MJ, Britten CM, van der Burg SH | CANCER IMMUNOLOGY IMMUNOTHERAPY | 2013 | 62 | 3 | 489 |
| 66 | Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols. | Filbert H, Attig S, Bidmon N, Renard BY, Janetzki S, Sahin U, Welters MJ, Ottensmeier C, van der Burg SH, Gouttefangeas C, Britten CM. | CANCER IMMUNOLOGY IMMUNOTHERAPY | 2013 | 62 | 4 | 615 |
| 67 | HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial. | van Poelgeest MI, Welters MJ, van Esch EM, Stynenbosch LF, Kerpershoek G, van Persijn van Meerten EL, van den Hende M, Löwik MJ, Berends-van der Meer DM, Fathers LM, Valentijn AR, Oostendorp J, Fleuren GJ, Melief CJ, Kenter GG, van der Burg SH. | JOURNAL OF TRANSLATIONAL MEDICINE | 2013 | 11 | 88 | |
| 68 | A Harmonized Approach to Intracellular Cytokine Staining Gating: Results from an International Multi-Consortia Proficiency Panel Conducted by the Cancer Immunotherapy Consortium (CIC/CRI) | McNeil LK, Price L, Britten CM, Jaimes M, Maecker H, Odunsi K, Matsuzaki J, Janet S. Staats, Jerill Thorpe, Jianda Yuan and Sylvia Janetzki | CYTOMETRY PART A | 2013 | |||
| 69 | HLA-A2-restricted Cytotoxic T Lymphocyte Epitopes from Human Hepsin as Novel Targets for Prostate Cancer Immunotherapy | Guo J, Li G, Tang J, Cao XB, Zhou QY, Fan ZJ, Zhu B, Pan XH | SCANDINAVIAN JOURNAL IMMUNOLOGY | 2013 | 31 | ||
| 70 | Quality control, analysis and secure sharing of Luminex® immunoassay data using the open source LabKey Server platform. | Eckels J, Nathe C, Nelson EK, Shoemaker SG, Nostrand EV, Yates NL, Ashley VC, Harris LJ, Bollenbeck M, Fong Y, Tomaras GD, Piehler B. | BMC BIOINFORMATICS | 2013 | 145 | ||
| 71 | Immune responses to cancer: are they potential biomarkers of prognosis? | Whiteside TL . | FRONTIERS ONCOLOGY | 2013 | 107 | ||
| 72 | Biomarkers in T-cell therapy clinical trials | Lacey, S.F., Kalos, M. | CYTOTHERAPY | 2013 | 15 | 6 | 632 |
| 73 | Pushing the frontiers of T-cell vaccines: Accurate measurement of human T-cell responses | Saade, F., Gorski, S.A., Petrovsky, N. | EXPERT REVIEW OF VACCINES | 2012 | 11 | 12 | 1459 |
| 74 | Neue perspektiven in der immunologischen krebstherapie | [Cancer immunotherapy - Novel perspectives] | Rothschild, S.I., Zippelius, A. | THERAPEUTISCHE UMSCHAU | 2012 | 69 | 10 | 559 |
| 75 | Evolution of end points for cancer immunotherapy trials | Hoos, A | ANNALS OF ONCOLOGY | 2012 | 23 | viii47 | |
| 76 | Cardiovascular toxicity and titin cross-reactivity of affinity enhanced T cells in myeloma and melanoma | Linette GP, Stadtmauer EA, Maus MV, Rapoport AP, Levine BL, Emery L, Litzky L, Bagg A, Carreno BM, Cimino PJ, Binder-Scholl GK, Smethurst DP, Gerry AB, Pumphrey NJ, Bennett AD, Brewer JE, Dukes J, Harper J, Tayton-Martin HK, Jakobsen BK, Hassan NJ, Kalos M, June CH | BLOOD | 2013 | Epub | ||
| 77 | CD39 is involved in mediating suppression by Mycobacterium bovis BCG-activated human CD8+ CD39+regulatory T cells. | Boer MC, van Meijgaarden KE, Bastid J, Ottenhoff TH, Joosten SA | EUROPEAN JOURNAL IMMUNOLOGY | 2013 | Epub | ||
| 78 | Conference Scene: Immune signatures in the tumor and beyond | Kandalaft LE, Kalos M, Melief CLM, Speiser DE & Coukos G. | FUTURE MEDICINE | 2012 | 4 | 8 | 761 |
| 79 | Approaches to Immunologic Monitoring of Clinical Trials | Butterfield LH, Vujanovic L, Pardee A | THE TUMOR IMMUNOENVIRONMENT | 2013 | 663 | ||
| 80 | Systems biological approaches to measure and understand vaccine immunity in humans | Shuzhao Li, Helder I. Nakaya, Dmitri A. Kazmin, Jason Z. Oh, Bali Pulendran | SEMINARS IN IMMUNOLOGY | 2013 | Epub | ||
| 81 | Alternative variants of the human hydin are novel cancer-associated antigens recognized by adaptive immunity | Karoline Laske, Yury V. Shebzukhov, Ludger Grosse-Hovest, Dmitri V. Kuprash, Svetlana V. Khlgatian, Ekaterina P. Koroleva, Alexey Y. Sazykin, Dmitry N. Penkov, Pavel V. Belousov, Stefan Stevanovic, Verona Vass, Steffen Walter, David Eisel, Barbara Schmid-Horch, Sergei A. Nedospasov, Hans-Georg Rammensee, and Cecile Gouttefangeas | CANCER IMMUNOLOGY RESEARCH | 2013 | Epub | ||
| 82 | Structured reporting of T cell assay results | Janetzki, S., Hoos, A., Melief, C.J.M., Odunsi, K., Romero, R., and Britten, C.M. | CANCER IMMUNITY | 2013 | 13 | 2 | 13 |
| 83 | T cell immune monitoring assays to guide the development of new cancer vaccines | Britten CM, Janetzki S, Gouttefangeas C, Welters MJP, Kalos M, Ottensmeier C, Hoos A, Van der Burgh S | CANCER VACCINES: FROM RESEARCH TO CLINICAL PRACTICE | 2011 | 2nd Edition | Chapter 12 | 156 |
| 84 | Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma | Linette GP, Stadtmauer EA, Maus MV, Rapoport AP, Levine BL, Emery L, Litzky L, Bagg A, Carreno BM, Cimino PJ, Binder-Scholl GK, Smethurst DP, Gerry AB, Pumphrey NJ, Bennett AD, Brewer JE, Dukes J, Harper J, Tayton-Martin HK, Jakobsen BK, Hassan NJ, Kalos M, June CH | BLOOD | 2013 | Epub | ||
| 85 | Stromal and hematopoietic cells in secondary lymphoid organs: partners in immunity. | Malhotra D, Fletcher AL, Turley SJ. | IMMUNOL REV | 2013 | 251 | 1 | 160 |
| 86 | Recent progress in canine tumor vaccination: potential applications for human tumor vaccines. | Sofie Denies, Niek N Sanders | EXPERT REV VACCINES | 2012 | 11 | 11 | 1375 |
| 87 | Dendritic cell engineering for tumor immunotherapy: from biology to clinical translation. | Arpit Bhargava, Dinesh Mishra, Smita Banerjee, Pradyumna Kumar Mishra | IMMUNOTHERAPY | 2012 | 4 | 7 | 703 |
| 88 | Immunological monitoring to rationally guide AAV gene therapy. | Britten CM, Walter S and Janetzki S | FRONTIERS IN IMMUNOLOGY | 2013 | 4 | 273 | 1 |
| 89 | A Helicopter Perspective on TB Biomarkers: Pathway and Process Based Analysis of Gene Expression Data Provides New Insight into TB Pathogenesis | Joosten SA, Fletcher HA, Ottenhoff THM | PLoS ONE | 2013 | 8 | 9 | |
| 90 | Overnight Resting of PBMC Changes Functional Signatures of Antigen Specific T- Cell Responses: Impact for Immune Monitoring within Clinical Trials | Sarah Kutscher, Claudia J. Dembek, Simone Deckert, Carolina Russo, Nina Koerber, Johannes R. Bogner, Fabian Geisler, Andreas Umgelter, Michael Neuenhahn, Julia Albrecht, Antonio Cosma, Ulrike Protzer, Tanja Bauer | PLOS ONE | 2013 | 8 | 10 | e76215 |
| 91 | Repositioning therapeutic cancer vaccines in the dawning era of potent immune interventions | Adrian Bot, Francesco Marincola, and Kent A Smith | EXPERT REVIEW OF VACCINES | 2013 | 12 | 10 | 1219 |
| 92 | Report from the second cytomegalovirus and immunosenescence workshop. | Mark Wills, Arne Akbar, Mark Beswick, et al. | IMMUNITY & AGEING | 2011 | 8 | 1 | 10 |
| 93 | Mobilizing and evaluating anticancer T cells: pitfalls and solutions | Céline Robert-Tissot, Linh T Nguyen, Pamela S Ohashi, and Daniel E Speiser | EXPERT REVIEW OF VACCINES | 2013 | Epub | doi: 10.1586/14760584.2013.843456 | |
| 94 | Assessment of Immune Responses in Biotherapy Trials and Clinical Endpoints | Whiteside, TL | ADVANCES IN TUMOR IMMUNOLOGY AND IMMUNOTHERAPY; CURRENT CANCER RESEARCH | 2014 | Rosenblatt, J.D.; Podack, E.R.; Barber, G.N.; Ochoa, A. (Eds.) | Springer New York | 343 |
| 95 | The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study. | de Vos van Steenwijk PJ, van Poelgeest MI, Ramwadhdoebe TH, et al. | CANCER IMMUNOLOGY IMMUNOTHERAPY | 2013 | Epub | ||
| 96 | Multimer monitoring of CMV-specific T cells in research and in clinical applications | Sylvia Borchers, Justyna Ogonek, Pavankumar Reddy Varanasi, Sabine Tischer, Melanie Bremm, Britta Eiz-Vesper, Ulrike Koehl, Eva Maria Weissinger | DIAGNOSTIC MICROBIOLOGY & INFECTIOUS DISEASE | 2013 | Epub | doi:10.1016/j.diagmicrobio.2013.11.007 | |
| 97 | Biomarkers for immune intervention trials in type 1 diabetes | Mallone, R., Roep, B.O | CLINICAL IMMUNOLOGY | 2013 | 149 | 3 | 286 |
| 98 | Identification of CDCA1-derived long peptides bearing both CD4+ and CD8+ T-cell epitopes: CDCA1-specific CD4+ T-cell immunity in cancer patients | Tomita, Y., Yuno, A., Tsukamoto, H., Senju, S., Yoshimura, S., Osawa, R., Kuroda, Y., (...), Nishimura, Y. | INTERNATIONAL JOURNAL OF CANCER | 2014 | 134 | 2 | 352 |
| 99 | Maximizing output from current glioma vaccine trials to construct robust next-generation immunotherapies | Migliorini, D., Dietrich, P.-Y., Walker, P.R. | IMMUNOTHERAPY | 2013 | 5 | 11 | 1147 |
| 100 | Identification of promiscuous KIF20A long peptides bearing both CD4 + and CD8+ T-cell epitopes: KIF20A-specific CD4 + T-cell immunity in patients with malignant tumor | Tomita, Y., Yuno, A., Tsukamoto, H., Senju, S., Kuroda, Y., Hirayama, M., Irie, A., (...), Nishimura, Y. | CLINICAL CANCER RESEARCH | 2013 | 19 | 16 | 4508 |
| 101 | Cancer vaccines: Identification of biomarkers predictive of clinical efficacy | Harrop, R. | HUMAN VACCINES AND IMMUNOTHERAPEUTICS | 2013 | 9 | 4 | 800 |
| 102 | Vaccine against autoimmune disease: Antigen-specific immunotherapy | Anderson, R.P., Jabri, B | CURRENT OPINION IN IMMUNOLOGY | 2013 | 25 | 3 | 410 |
| 103 | Tumor-Infiltrating Lymphocytes and Their Role in Solid Tumor Progression | Whiteside, T.L. | INTERACTIONS OF IMMUNE AND CANCER CELLS | 2014 | Srpinger | doi:10.1007/978-3-7091-1300-4_6 | 111 |
| 104 | Cancer, Aging and Immune Reconstitution | Zanussi, Stefania; Serraino, Diego; Dolcetti, Riccardo; Berretta, Massimiliano; Paoli, Paolo D. | ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY | 2013 | 13 | 9 | 1310 |
| 105 | Dendritic cells in cancer immunotherapy clinical trials: are we making progress? | Lisa H. Butterfield | FRONT. IMMUNOL. | 2013 | Epub | doi: 10.3389/fimmu.2013.00454 | |
| 106 | Computational resources for high-dimensional immune analysis from the Human Immunology Project Consortium | Vladimir Brusic, Raphael Gottardo, Steven H Kleinstein, Mark M Davis, Mark M Davis, David A Hafler, Helen Quill, A Karolina Palucka, Gregory A Poland, Bali Pulendran, Ellis L Reinherz, Kenneth D Stuart & Alkis Togias for HIPC steering committee | NATURE BIOTECHNOLOGY | 2014 | Epub | doi:10.1038/nbt.2777 | |
| 107 | Implementing combinatorial immunotherapeutic regimens against cancer: The concept of immunological conditioning | Dominik Wolf, Annkristin Heine, Peter Brossart | ONCOIMMUNOLOGY | 2013 | Epub | 3:e27588 | |
| 108 | Specific active immunotherapy with a VEGF vaccine in patients with advanced solid tumors. Results of the CENTAURO antigen dose escalation phase I clinical trial | J.V. Gavilondoa, F. Hernández-Bernala, M. Ayala Ávilaa, A.V. de la Torreb, J. de la Torrec, Y. Morera-Díaza, M. Bequet-Romeroa, J. Sáncheza, C.M. Valenzuelaa, Y. Martínb, K.-H. Selman-Houseinc, A. Garabitob, O.C. Lazoa, for the CENTAURO Group of Investigators | VACCINE | 2014 | Epub | http://dx.doi.org/10.1016/j.vaccine.2013.11.102 | |
| 109 | Challenges in the development of a survivin vaccine (SurVaxM) for malignant glioma | Robert A Fenstermaker and Michael J Ciesielski | EXPERT REVIEW OF VACCINES | 2014 | 13 | 3 | 377 |
| 110 | Immune Monitoring in Cancer Vaccine Clinical Trials: Critical Issues of Functional Flow Cytometry-Based Assays. | Iole Macchia, Francesca Urbani, Enrico Proietti | BIOMED RESEARCH INTERNATIONAL | 2013 | EPub | DOI:10.1155/2013/726239 | |
| 111 | An Enzyme-Linked Immunospot Assay for the Detection of Human Respiratory Syncytial Virus F-Specific IFNγ-producing T Cells | Patton K, Aslam S, Lin J, Yu L, Lambert S, Dawes G, Esser MT, Woo J, Janetzki S, Cherukuri A. | CLINICAL AND VACCINE IMMUNOLOGY | 2014 | EPub | http://cvi.asm.org/content/early/2014/02/20/CVI.00736-13.long | |
| 112 | Human papillomavirus 16 E2-, E6- and E7-specific T-cell responses in children and their mothers who developed incident cervical intraepithelial neoplasia during a 14-year follow-up of the Finnish Family HPV cohort. | Koskimaa HM, Paaso AE, Welters MJ, Grénman SE, Syrjänen KJ, van der Burg SH, Syrjänen SM | JOURNAL TRNALATIONAL MEDICINE | 2014 | 12 | 44 | |
| 113 | T-cell regulation in lepromatous leprosy. | Kidist Bobosha, Louis Wilson, Krista E van Meijgaarden, Yonas Bekele, Martha Zewdie, Jolien J van der Ploeg-van Schip, Markos Abebe, Jemal Hussein, Saraswoti Khadge, Kapil D Neupane, Deanna A Hagge, Ekaterina S Jordanova, Abraham Aseffa, Tom H M Ottenhoff, Annemieke Geluk | PLoS NEGLECTED TROPICAL DISEASES | 2014 | 8 | e2773 | |
| 114 | CD8+ Regulatory T Cells, and Not CD4+ T Cells, Dominate Suppressive Phenotype and Function after In Vitro Live Mycobacterium bovis-BCG Activation of Human Cells. | Boer MC, van Meijgaarden KE, Joosten SA, Ottenhoff TH | PLOS ONE | 2014 | 9 | e94192 | |
| 115 | Thymic Stromal Lymphopoietin-Mediated Extramedullary Hematopoiesis Promotes Allergic Inflammation. | Mark C Siracusa, Steven A Saenz, Elia D Tait Wojno, Brian S Kim, Lisa C Osborne, Carly G Ziegler, Alain J Benitez, Kathryn R Ruymann, Donna L Farber, Patrick M Sleiman, Hakon Hakonarson, Antonella Cianferoni, Mei-Lun Wang, Jonathan M Spergel, Michael R Comeau, David Artis | IMMUNITY | 2013 | 39 | 1158 | |
| 116 | Immunostimulatory activity of lifespan-extending agents. | José Manuel Bravo-San Pedro, Laura Senovilla | AGING | 2013 | 5 | 793 | |
| 117 | Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials. | Sambor A, Garcia A, Berrong M, Pickeral J, Brown S, Rountree W, Sanchez A, Pollara J, Frahm N, Keinonen S, Kijak GH, Roederer M, Levine G, D'Souza MP, Jaimes M, Koup R, Denny T, Cox J, Ferrari G. | JOURNAL OF IMMUNOLOGICAL METHODS | 2014 | Epub | doi: 10.1016/j.jim.2014.04.005 | |
| 118 | The role of the reporting framework MIATA within current efforts to advance immune monitoring | Janetzki S, Britten CM | JOURNAL OF IMMUNOLOGICAL METHODS | 2014 | Epub | doi: 10.1016/j.jim.2014.05.003 | |
| 119 | Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8+ T cells with detection by ELISPOT and HLA-multimer staining. | Lindsey Chudley, Katy J. McCann, Adam Coleman, Angelica M. Cazaly, Nicole Bidmon, Cedrik M. Britten, Sjoerd H. van der Burg, Cecile Gouttefangeas, Camilla Jandus, Karoline Laske, Dominik Maurer, Pedro Romero, Helene Schröder, Linda F. M. Stynenbosch, Steffen Walter, Marij J. P. Welters, Christian H. Ottensmeier | CANCER IMMUNOL IMMUNOTHER | 2014 | Epub | http://link.springer.com/article/10.1007/s00262-014-1593-0 | |
| 120 | Evaluation of tumor response to cytokine-induced killer cells therapy in malignant solid tumors. | Li XD, Ji M, Zheng X, Ning ZH, Wu J, Lu B, Wu CP, Jiang JT | JOURNAL TRANSLATIONAL MEDICINE | 2014 | 12 | 12 | 215 |
| 121 | Cell-Mediated Immunity to AAV Vectors, Evolving Concepts and Potential Solutions | Basner-Tschakarjan E, Mingozzi F. | FRONTIERS IN IMMUNOLOGY | 2014 | EPUB | doi: 10.3389/fimmu.2014.00350 | |
| 122 | TRANSVAC workshop on standardisation and harmonisation of analytical platforms for HIV, TB and malaria vaccines: 'How can big data help?'. | Dutruel C, Thole J, Geels M, Mollenkopf HJ, Ottenhoff T, Guzman CA, Fletcher HA, Leroy O, Kaufmann SH. | VACCINE | 2014 | EPUB | DOI: 10.1016/j.vaccine.2014.06.014 | |
| 123 | Challenges in the development of a survivin vaccine (SurVaxM) for malignant glioma. | Fenstermaker RA, Ciesielski MJ | EXPERT REVIEWS OF VACCINES | 2014 | Epub | doi:10.1586/14760584.2014.881255 | |
| 124 | Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors. | Lennerz V, Gross S, Gallerani E, Sessa C, Mach N, Boehm S, Hess D, von Boehmer L, Knuth A, Ochsenbein AF, Gnad-Vogt U, Zieschang J, Forssmann U, Woelfel T, Kaempgen E. | CANCER IMMUNOL IMMUNOTHER | 2014 | Epub | doi: 10.1007/s00262-013-1516-5 | |
| 125 | Comparability and reproducibility of biomedical data. | Huang Y, Gottardo R | BRIEF BIOINFORM | 2013 | EPub | doi: 10.1093/bib/bbs078 | |
| 126 | Introduction to a Special Issue of the Journal of Immunological Methods: Building Global Resource Programs to Support HIV/AIDS Clinical Trial Studies | Ana M. Sanchez, Thomas N. Denny, and Maurice O’Gorman | JOURNAL OF IMMUNOLOGICAL METHODS | 2014 | EPub | doi: 10.1016/j.jim.2014.05.016 | |
| 127 | Effect of cryopreservation of peripheral blood mononuclear cells (PBMCs) on the variability of an antigen-specific memory B cell ELISpot: Variability of the memory B cell ELISpot assay. | Trück J, Mitchell R, Thompson AJ, Morales-Aza B, Clutterbuck EA, Kelly DF, Finn A, Pollard AJ. | HUM VACCIN IMMUNOTHER | 2014 | 10 | 8 | 1 |
| 128 | Bridging Basic Science and Clinical Research – The EASL Monothematic Conference on Translational Research in Viral Hepatitis | Boettler T, Moradpour D, Thimme R1, Zoulim F. | J HEPATOLOGY | 2014 | EPub | doi: 10.1016/j.jhep.2014.05.016 | |
| 129 | Cryopreservation of MHC multimers: Recommendations for quality assurance in detection of antigen specific T cells | Hadrup SR, Maurer D, Laske K, Frøsig TM, Andersen SR, Britten CM, van der Burg SH, Walter S, Gouttefangeas C. | CYTOMETRY PART A | 2014 | EPub | DOI: 10.1002/cyto.a.22575 | |
| 130 | Miniaturized and high-throughput assays for analysis of T-cell immunity specific for opportunistic pathogens and HIV. | Li Pira G, Ivaldi F, Starc N, Landi F, Locatelli F, Rutella S, Tripodi G, Manca F. | CLIN VACCINE IMMUNOL | 2014 | EPub | doi: 10.1128/CVI.00660-13 | |
| 131 | Stepping up ELISpot: Multi-Level Analysis in FluoroSpot Assays. | Janetzki S, Rueger M, Dillenbeck T. | CELLS | 2014 | 27 | 3 | 1102 |
| 132 | CIMT 2014: Next Waves in Cancer Immunotherapy - Report on the 12th Annual Meeting of the Association for Immunotherapy of Cancer | Mustafa Dikena, Sebastian Boegelb, Christian Grunwitzab, Lena Kranzab, Kerstin Reuterc, Niels van de Roemerab, Fulvia Vascotto, Mathias Vormehra & Sebastian Kreiter | HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2014 | EPub | DOI:10.4161/hv.29767 | |
| 133 | A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human | van Dissel JT, Joosten SA, Hoff ST, Soonawala D, Prins C, Hokey DA, O'Dee DM, Graves A, Thierry-Carstensen B, Andreasen LV, Ruhwald M, de Visser AW, Agger EM, Ottenhoff TH, Kromann I, Andersen P | VACCINE | 2014 | EPub | doi: 10.1016/j.vaccine.2014.10.036 | |
| 134 | Getting personal: Perspectives on individualized treatment duration in M/XDR-TB. | Heyckendorf , Olaru ID, Ruhwald M, Lange C. | Am J Respir Crit Care Med | 2014 | EPub | doi: 10.1164/rccm.201402-0363PP | |
| 135 | Sequential immune monitoring in patients with melanoma and renal cell carcinoma treated with high-dose interleukin-2: immune patterns and correlation with outcome | David M. Foureau, Asim Amin, Richard L. White, William Anderson, Chase P. Jones, Terry Sarantou, Iain H. McKillop, Jonathan C. Salo | CANCER IMMUNOL IMMUNOTHER | 2014 | EPub | http://link.springer.com/article/10.1007%2Fs00262-014-1605-0 | |
| 136 | Flow Cytometry in Cancer Immunotherapy: Applications, Quality Assurance, and Future | Cécile Gouttefangeas, Steffen Walter, Marij J. P. Welters, Christian Ottensmeier, Sjoerd H. van der Burg, Cedrik M. Britten, Cliburn Chan | in: Cancer Immunology | 2015 | http://link.springer.com/chapter/10.1007/978-3-662-44006-3_25 | 471-490 | |
| 137 | Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies | Gregory L. Beatty, Andrew R. Haas, Marcela V. Maus, Drew A. Torigian, Michael C. Soulen, Gabriela Plesa, Anne Chew, Yangbing Zhao, Bruce L. Levine, Steven M. Albelda, Michael Kalos, and Carl H. June | CANCER IMMUNOL RES | 2014 | EPub | doi: 10.1158/2326-6066.CIR-13-0170 | |
| 138 | Improvement of IFNg ELISPOT Performance Following Overnight Resting of Frozen PBMC Samples Confirmed Through Rigorous Statistical Analysis | Radleigh Santos, Alcinette Buying, Nazila Sabri, John Yu, Anthony Gringeri, James Bender, Sylvia Janetzki , Clemencia Pinilla and Valeria A. Judkowski | CELLS | 2015 | EPub | doi:10.3390/cells4010001 | |
| 139 | Abacavir-Reactive Memory T Cells Are Present in Drug Naïve Individuals | Andrew Lucas, Michaela Lucas, Anette Strhyn, Niamh M. Keane, Elizabeth McKinnon, Rebecca Pavlos, Ellen M. Moran, Viola Meyer-Pannwitt, Silvana Gaudieri, Lloyd D’Orsogna, Spyros Kalams, David A. Ostrov, Søren Buus, Bjoern Peters, Simon Mallal, Elizabeth Phillips | PLOS ONE | 2015 | EPub | http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0117160 | |
| 140 | Human CD8+ T-cells Recognizing Peptides from Mycobacterium tuberculosis (Mtb) Presented by HLA-E Have an Unorthodox Th2-like, Multifunctional, Mtb Inhibitory Phenotype and Represent a Novel Human T-cell Subset | Krista E. van Meijgaarden, Mariëlle C. Haks, Nadia Caccamo, Francesco Dieli, Tom H. M. Ottenhoff , Simone A. Joosten | PLOS PATHOGEN | 2015 | EPub | DOI: 10.1371/journal.ppat.1004671 | |
| 141 | Human fibrocytic myeloid-derived suppressor cells express IDO and promote tolerance via Treg-cell expansion. | Zoso A, Mazza EM, Bicciato S, Mandruzzato S, Bronte V, Serafini P, Inverardi L. | EUR J IMMUNOL | 2014 | EPub | doi: 10.1002/eji.201444522. | |
| 142 | Data analysis as a source of variability of the HLA-peptide multimer assay: from manual gating to automated recognition of cell clusters | Cécile Gouttefangeas, Cliburn Chan, Sebastian Attig, Tania T. Køllgaard, Hans-Georg Rammensee, Stefan Stevanović, Dorothee Wernet, Per thor Straten, Marij J. P. Welters, Christian Ottensmeier, Sjoerd H. van der Burg, Cedrik M. Britten | CANCER IMMUNOL IMMUNOTHER | 2015 | 64 | 5 | 585 |
| 143 | Cancer Immunotherapy Confers a Global Benefit | Zahra Aryan, Håkan Mellstedt, Nima Rezaei | CANCER IMMUNOL | 2015 | 1 | 1 | 1 |
| 144 | Cancer immunotherapy drives implementation science in oncology | Daniel E Speiser, Lukas Flatz | HUMAN VACC IMMUNOTHER | 2014 | EPub | DOI:10.4161/21645515.2014.983000 | |
| 145 | Minimum information standards. | James A Hutchinson | TRANSPLANTATION | 2015 | EPub | DOI:10.1097/TP.0000000000000693 | |
| 146 | Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions | Yannick Willemen, Johan M. J. Van den Bergh, Eva Lion, Sébastien Anguille, Vicky A. E. Roelandts, Heleen H. Van Acker, Steven D. I. Heynderickx, Barbara M. H. Stein, Marc Peeters, Carl G. Figdor, Viggo F. I. Van Tendeloo, I. Jolanda de Vries, Gosse J. Adema, Zwi N. Berneman, Evelien L. J. Smits | CANCER IMMUNOL IMMUNOTHER | 2015 | EPub | doi: 10.1007/s00262-015-1688-2 | |
| 147 | Generation of TCR-Engineered T Cells and Their Use To Control the Performance of T Cell Assays. | Bidmon N, Attig S, Rae R, Schröder H, Omokoko TA, Simon P, Kuhn AN, Kreiter S, Sahin U, Gouttefangeas C, van der Burg SH, Britten CM. | J IMMUNOL | 2015 | EPub | doi: 10.4049/jimmunol.1400958 | |
| 148 | Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study. | McCann KJ, Godeseth R, Chudley L, Mander A, Di Genova G, Lloyd-Evans P, Kerr JP, Malykh VB, Jenner MW, Orchard KH, Stevenson FK, Ottensmeier CH. | CANCER IMMUNOL IMMUNOTHER | 2015 | EPub | DOI 10.1007/s00262-015-1703-7 | |
| 149 | Quantitative TCR:pMHC Dissociation Rate Assessment by NTAmers Reveals Antimelanoma T Cell Repertoires Enriched for High Functional Competence | Philippe O. Gannon, Sébastien Wieckowski, Petra Baumgaertner, Michaël Hebeisen, Mathilde Allard, Daniel E. Speiser and Nathalie Rufer | J IMMUNOL | 2015 | EPub | doi: 10.4049/jimmunol.1403145 | |
| 150 | Immune cell profiling to guide therapeutic decisions in rheumatic diseases | Joerg Ermann, Deepak A. Rao, Nikola C. Teslovich, Michael B. Brenner & Soumya Raychaudhuri | NAT REV RHEUM | 2015 | EPub | doi:10.1038/nrrheum.2015.71 | |
| 151 | Adoptive T-cell therapy: a need for standard immune monitoring | Yarne Klaver, Andre Kunert, Stefan Sleijfer, Reno Debets & Cor HJ Lamers | IMMUNOTHERAPY | 2015 | EPub | doi:10.2217/imt.15.23 | |
| 152 | Neonatal regulatory T cells have reduced capacity to suppress dendritic cell function | Cesar M. Rueda, Maria Moreno-Fernandez, Courtney M. Jackson, Suhas G. Kallapur, Alan H. Jobe andClaire A. Chougnet | EUR J IMMUNOL | 2015 | EPub | DOI: 10.1002/eji.201445371 | |
| 153 | Guidelines for the automated evaluation of Elispot assays. | Janetzki S, Price L, Schroeder H, Britten CM, Welters MJ, Hoos A. | NAT PROTOC | 2015 | EPub | DOI: 10.1038/nprot.2015.068 | |
| 154 | Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry. | Santegoets SJ, Dijkgraaf EM, Battaglia A, Beckhove P, Britten CM, Gallimore A, Godkin A, Gouttefangeas C, de Gruijl TD, Koenen HJ, Scheffold A, Shevach EM, Staats J, Taskén K, Whiteside TL, Kroep JR, Welters MJ, van der Burg SH. | CANCER IMMUNOL IMMUNOTHER | 2015 | EPub | DOI: 10.1007/s00262-015-1729-x | |
| 155 | NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma. | RapoportAP,StadtmauerEA, Binder-Scholl GK, Goloubeva O, Vogl DT, Lacey SF, Badros AZ, Garfall A, Weiss B, Finklestein J, Kulikovskaya I, Sinha SK, Kronsberg S, Gupta M, Bond S, Melchiori L, Brewer JE, Bennett AD, Gerry AB, Pumphrey NJ, Williams D, Tayton-Martin HK, Ribeiro L, Holdich T, Yanovich S, Hardy N, Yared J, Kerr N, Philip S, Westphal S, Siegel DL, Levine BL, Jakobsen BK, Kalos M, June CH. | NAT MED | 2015 | EPub | doi: 10.1038/nm.3910 | |
| 156 | Detection and Tracking of NY-ESO-1-Specific CD8+ T Cells by High-Throughput T Cell Receptor β (TCRB) Gene Rearrangements Sequencing in a Peptide-Vaccinated Patient. | Miyai M, Eikawa S, Hosoi A, Iino T, Matsushita H, Isobe M, Uenaka A, Udono H, Nakajima J, Nakayama E, Kakimi K. | PLOS ONE | 2015 | EPub | doi: 10.1371/journal.pone.0136086 | |
| 157 | Critical issues in cancer vaccine trial design | Guy T. Clifton, Holbrook E. Kohrt, George E. Peoples | VACCINE | 2015 | EPub | doi:10.1016/j.vaccine.2015.09.019 | |
| 158 | Immunotherapies and immune biomarkers in Type 1 diabetes: A partnership for success | Rekers NV, von Herrath MG, Wesley JD | CLIN IMMUNOL | 2015 | EPub | doi: 10.1016/j.clim.2015.05.021 | |
| 159 | Analysis of cell-mediated immune responses in support of dengue vaccine development efforts | Alan L. Rothman, Jeffrey R. Currier, Heather L. Friberg, Anuja Mathew | VACCINE | 2015 | EPub | doi:10.1016/j.vaccine.2015.09.104 | |
| 160 | Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis Vaccines | Smith SG, Smits K, Joosten SA, van Meijgaarden KE, Satti I, Fletcher HA, Caccamo N, Dieli F, Mascart F, McShane H, Dockrell HM, Ottenhoff TH; TBVI TB Biomarker Working Group. | PLOS ONE | 2015 | EPub | doi: 10.1371/journal.pone.0138042 | |
| 161 | Enzyme-Linked ImmunoSpot (ELISpot) for Single-Cell Analysis. | Janetzki S, Rabin R. | METHODS MOL BIOL | 2015 | EPub | doi: 10.1007/978-1-4939-2987-0_3 | |
| 162 | Short peptide vaccine induces CD4+ T helper cells in patients with different solid cancers. | Stefanie Gross, Volker Lennerz, Elisa Gallerani, Nicolas Nicolas Mach, Steffen Böhm, Dagmar Hess, Lotta von Boehmer, Alexander Knuth, Adrian Ochsenbein, Ulrike S Gnad-Vogt, Ulf Forssmann, Thomas Woelfel, and Eckhart Kaempgen | CANCER IMMUNOL RES | 2015 | EPub | doi: 10.1158/2326-6066.CIR-15-0105 | |
| 163 | Immunomonitoring in glioma immunotherapy: current status and future perspectives | Jonathan B. Lamano, Leonel Ampie, Winward Choy, Kartik Kesavabhotla, Joseph D. DiDomenico, Daniel E. Oyon, Andrew T. Parsa, Orin Bloch | J NEURO-ONCOL | 2015 | EPub | http://link.springer.com/article/10.1007/s11060-015-2018-4 | |
| 164 | A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma | Jeong-Hoon Lee, Yoon Lee, Minjong Lee, Min Kyu Heo, Jae-Sung Song, Ki-Hwan Kim, Hyunah Lee, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh, Yong-Soo Bae and Yoon Jun Kim | BR J CANCER | 2015 | EPub | doi:10.1038/bjc.2015.430 | |
| 165 | Mutanome Engineered RNA Immunotherapy – Towards patient-centered tumor vaccination | Mathias Vormehr, Barbara Schroers, Sebastian Boegel, Martin Loewer, Oezlem Tuereci, and Ugur Sahin | J IMMUNOL RES | 2015 | EPub | http://downloads.hindawi.com/journals/jir/aip/595363.pdf | |
| 166 | The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research | R Hohlfeld, K Dornmair, E Meinl, H Wekerle | LANCET NEUROL | 2015 | EPub | doi: 10.1016/S1474-4422(15)00313-0 | |
| 167 | Human papillomavirus 16-specific cell-mediated immunity in children born to mothers with incident cervical intraepithelial neoplasia (CIN) and to those constantly HPV negative | Hanna-Mari Koskimaa, Anna Paaso, Marij J. P. Welters, Seija Grenman, Kari Syrjänen, Sjoerd H. van der Burg and Stina Syrjänen | J TRANSL MED | 2015 | EPub | doi:10.1186/s12967-015-0733-4 | |
| 168 | A framework for T cell assays | Cedrik M. Britten, Sjoerd H. van der Burg, Cécile Gouttefangeas | ONCOTARGET | 2016 | EPub | doi: 10.18632/oncotarget.6181 | |
| 169 | The use and abuse of immune indices in nutritional immunology studies | Ramesh K. Selvaraj, Revathi Shanmuga-sundara and Ravikumar Rengasamy | J APPL POULT RES | 2016 | EPub | doi: 10.3382/japr/pfv077 | |
| 170 | Mismatch in epitope specificities between IFNγ inflamed and uninflamed conditions leads to escape from T lymphocyte killing in melanoma. | Woods K, Knights AJ, Anaka M, Schittenhelm RB, Purcell AW, Behren A, Cebon J | J IMMUNOTHER CANCER | 2016 | EPub | http://jitc.biomedcentral.com/articles/10.1186/s40425-016-0111-7 | |
| 171 | 2015 Guidance on cancer immunotherapy development in early‐phase clinical studies | Guidance Development Review Committee et al. | CANCER SCI | 2016 | EPub | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714668/ | |
| 172 | Semi-automated and standardized cytometric procedures for multi-panel and multi-parametric whole blood immunophenotyping. | Hasan M, Beitz B, Rouilly V, Libri V, Urrutia A, Duffy D, Cassard L, Di Santo JP, Mottez E, Quintana-Murci L, Albert ML, Rogge L; Milieu Intérieur Consortium. | CLIN IMMUNOL | 2015 | EPub | http://www.sciencedirect.com/science/article/pii/S1521661614002861 | |
| 173 | Development of immuno-oncology drugs — from CTLA4 to PD1 to the next generations | Hoos A | NAT REV DRUG DISCOV | 2016 | EPub | http://www.nature.com/nrd/journal/vaop/ncurrent/full/nrd.2015.35.html | |
| 174 | First Proposal of Minimum Information About a Cellular Assay for Regenerative Medicine | Sakurai K, Kurtz A, Stacey G, Sheldon M, Fujibuchi W | STEM CELLS TRANSL MED | 2016 | EPub | http://stemcellstm.alphamedpress.org/content/early/2016/07/12/sctm.2015-0393.full.pdf | |
| 175 | Tumor antigen–specific T cells for immune monitoring of dendritic cell–treated glioblastoma patients | Isabelle Müller, Dominik Altherr, Matthias Eyrich, Brigitte Flesch, Kim S. Friedmann, Ralf Ketter, Joachim Oertel, Eva C. Schwarz, Antje Technau, Steffi Urbschat, Hermann Eichler | CYTOTHERAPY | 2016 | EPub | doi: http://dx.doi.org/10.1016/j.jcyt.2016.05.014 | |
| 176 | Patients with Tuberculosis Have a Dysfunctional Circulating B-Cell Compartment, Which Normalizes following Successful Treatment. | Joosten SA, van Meijgaarden KE, Del Nonno F, Baiocchini A, Petrone L, Vanini V, Smits HH, Palmieri F, Goletti D, Ottenhoff TH. | PLOS PATHOG | 2016 | EPub | http://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1005687 | |
| 177 | Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines | Spencer D. Martin, Scott D. Brown, Darin A. Wick, Julie S. Nielsen, David R. Kroeger, Kwame Twumasi-Boateng, Robert A. Holt, Brad H. Nelson | PLOS One | 2016 | Epub | http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0155189 | |
| 178 | Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines. | Türeci Ö, Vormehr M, Diken M, Kreiter S, Huber C, Sahin U | CLIN CANCER RES | 2016 | EPub | DOI: 10.1158/1078-0432.CCR-15-1509 | |
| 179 | Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunological and Clinical Outcomes | Katy J McCann, Ann Mander, Angelica Cazaly, Lindsey Chudley, Jana Stasakova, Stephen M Thirdborough, Andrew King, Paul Lloyd-Evans, Emily Buxton, Ceri Edwards, Sarah Halford, Andrew Bateman, Ann O'Callaghan, Sally Clive, Alan Anthoney, Duncan I. Jodrell, Toni Weinschenk, Petra Simon, Ugur Sahin, Gareth J Thomas, Freda K Stevenson, Christian H Ottensmeier | CLIN CANCER RES | 2016 | EPub | DOI: 10.1158/1078-0432.CCR-15-2507 | |
| 180 | Validation of an IFNγ/IL2 FluoroSpot assay for clinical trial monitoring | Nina Körber, Uta Behrends, Alexander Hapfelmeier, Ulrike Protzer and Tanja Bauer | J TRANSL MED | 2016 | EPub | https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-016-0932-7 | |
| 181 | Managing Multi-center Flow Cytometry Data for Immune Monitoring. | White S, Laske K, Welters MJ, Bidmon N, van der Burg SH, Britten CM, Enzor J, Staats J, Weinhold KJ, Gouttefangeas C, Chan C | CANCER INFORM | 2015 | Epub | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463798/pdf/cin-suppl.7-2014-111.pdf | |
| 182 | Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults | Mardi C. Boer, Corine Prins, Krista E. van Meijgaarden, Jaap T. van Dissel, Tom H. M. Ottenhoff, and Simone A. Joosten | CLIN VACCINE IMMUNOL | 2015 | EPub | http://cvi.asm.org/content/22/7/778.long | |
| 183 | Multi-peptide immunotherapeutic vaccine for renal cell carcinoma: getting the troops all worked up. | Yaddanapudi K, Eaton JW | TRANSL ANDROL UROL | 2012 | Epub | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160063/pdf/tau-01-04-229.pdf | |
| 184 | Validation of immunomonitoring methods for application in clinical studies: The HLA-peptide multimer staining assay. | Chandran PA, Laske K, Cazaly A, Rusch E, Schmid-Horch B, Rammensee HG, Ottensmeier CH, Gouttefangeas C | CYTOMETRY B | 2016 | EPub | DOI: 10.1002/cyto.b.21397 | |
| 185 | Reduced potency of cytotoxic T lymphocytes from patients with high-risk myelodysplastic syndromes | Kristoffer Sand, Jakob Theorell, Øystein Bruserud, Yenan T. Bryceson, Astrid Olsnes Kittang | CANCER IMMUNOL IMMUNOTHER | 2016 | EPub | doi:10.1007/s00262-016-1865-y | |
| 186 | Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies | Phillip Lord, Rachel Spiering, Juan C. Aguillon, Amy E. Anderson, Silke Appel, Daniel Benitez-Ribas, Anja ten Brinke, Femke Broere, Nathalie Cools, Maria Cristina Cuturi, Julie Diboll, Edward K. Geissler, Nick Giannoukakis, Silvia Gregori, S. Marieke van Ham, Staci Lattimer, Lindsay Marshall, Rachel A. Harry, James A. Hutchinson, John D. Isaacs, Irma Joosten, Cees van Kooten, Ascension Lopez Diaz de Cerio, Tatjana Nikolic, Haluk Barbaros Oral, Ljiljana Sofronic-Milosavljevic, Thomas Ritter, Paloma Riquelme, Angus W. Thomson, Massimo Trucco, Marta Vives-Pi, Eva M. Martinez-Caceres, Catharien M.U. Hilkens | PEERJ | 2016 | EPub | https://peerj.com/articles/2300/ | |
| 187 | The importance of correctly timing cancer immunotherapy | Elham Beyranvand Nejad, Marij J.P. Welters, Ramon Arens & Sjoerd H. van der Burg | EXPERT OPINION ON BIOLOGICAL THERAPY | 2017 | EPub | http://www.tandfonline.com/doi/abs/10.1080/14712598.2017.1256388 | |
| 188 | Elispot for Rookies (And Experts too)) | Janetzki S | Springer Book Series "Techniques in Life Science and Biomedicine for the Non-Expert" | 2016 | EPub | https://link.springer.com/book/10.1007/978-3-319-45295-1 | |
| 189 | Immunostimulatory activity of lifespan-extending agents | Bravo-San Pedro JM, Senovilla L | AGING | 2013 | EPub | http://www.aging-us.com/article/100619/text | |
| 190 | Teaching advanced flow cytometry in Africa: 10 years of lessons learned | Nemes E, Burgers WA, Riou C, Andersen-Nissen E, Ferrari G, Gray CM, Scriba T. | CYTOMETRY A | 2016 | EPub | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5326675/ | |
| 191 | The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells. | Willemen Y, Van den Bergh JM, Bonte SM, Anguille S, Heirman C, Stein BM, Goossens H, Kerre T, Thielemans K, Peeters M, Van Tendeloo VF, Smits EL, Berneman ZN | ONCOTARGET | 2016 | EPub | http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path[]=12170&pubmed-linkout=1 | |
| 192 | Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation. | Masucci GV, Cesano A, Hawtin R, Janetzki S, Zhang J, Kirsch I, Dobbin KK, Alvarez J, Robbins PB, Selvan SR, et al. | J IMMUNOTHER CANCER | 2016 | EPub | https://jitc.biomedcentral.com/articles/10.1186/s40425-016-0178-1 | |
| 193 | Immuno-oncology combinations: raising the tail of the survival curve. | Harris SJ, Brown J, Lopez J, Yap TA. | CANCER BIOL MED | 2016 | EPub | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944548/ | |
| 194 | Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients | Gross S, Erdmann M, Haendle I, Voland S, Berger T, Schultz E, Strasser E, Dankerl P, Janka R, Schliep S, et al. | JCI INSIGHT | 2017 | EPub | https://insight.jci.org/articles/view/91438 | |
| 195 | First Proposal of Minimum Information About a Cellular Assay for Regenerative Medicine | Sakurai K, Kurtz A, Stacey G, Sheldon M, Fujibuchi W. | STEM CELLS TRANSL MED | 2016 | EPub | http://onlinelibrary.wiley.com/doi/10.5966/sctm.2015-0393/abstract | |
| 196 | Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical Outcomes | McCann KJ, Mander A, Cazaly A, Chudley L, Stasakova J, Thirdborough SM, King A, Lloyd-Evans P, Buxton E, Edwards C, Halford S, Bateman A, O'Callaghan A, Clive S, Anthoney A, Jodrell DI, Weinschenk T, Simon P, Sahin U, Thomas GJ, Stevenson FK, Ottensmeier CH | CLIN CANCER RES | 2016 | EPub | http://clincancerres.aacrjournals.org/content/22/19/4827.long | |
| 197 | A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma. | Donald M. O'Rourke, MacLean P Nasrallah, Arati Desai, Jan Joseph Melenhorst, Keith Mansfield, Jennifer J D Morrissette, Maria Martinez-Lage, Steven Brem, Eileen M Maloney, Angela Shen, Randi Isaacs, S. B. Mohan, Gabriela Plesa, Simon F Lacey, Jean-Marc Navenot, Zhaohui Zheng, Bruce L Levine, Hideho Okada, Carl H June, Jennifer L. Brogdon, Marcela V Maus | SCI TRANSL MED | 2017 | EPub | http://stm.sciencemag.org/content/9/399/eaaa0984 | |
| 198 | Intra‐ and inter‐individual variability of Aspergillus fumigatus reactive T‐cell frequencies in healthy volunteers in dependency of mould exposure in residential and working environment | Sebastian Wurster Philipp Weis Lukas Page Johanna Helm Maria Lazariotou Hermann Einsele Andrew J. Ullmann | MYCOSES | 2017 | EPub | https://onlinelibrary.wiley.com/doi/full/10.1111/myc.12643 | |
| 199 | Detailed characterization of human Mycobacterium tuberculosis specific HLA‐E restricted CD8+ T cells | Teresa Prezzemolo Krista E. van Meijgaarden Kees L.M.C. Franken Nadia Caccamo Francesco Dieli Tom H.M. Ottenhoff Simone A. Joosten | EUR J IMMUNOL | 2018 | EPub | https://onlinelibrary.wiley.com/doi/full/10.1002/eji.201747184 | |
| 200 | Immune Monitoring of Blood and Tumor Microenvironment | Petra Baumgaertner, Kalliopi Ioannidou, Daniel E. Speiser | ONCOIMMUNOLOGY | 2017 | EPub | https://link.springer.com/chapter/10.1007/978-3-319-62431-0_41 | |
| 201 | Preclinical and clinical development of neoantigen vaccines | L Li S P Goedegebuure W E Gillanders | ANAL ONCOL | 2017 | EPub | https://academic.oup.com/annonc/article/28/suppl_12/xii11/4747876 | |
| 202 | Serum immunoglobulin E response as a marker for unfavorable prognosis following cholesteryl pullulan-MAGE A4 vaccination | Abiko T, Tsuchikawa T, Miyauchi K, Wada M, Kyogoku N, Shichinohe T, Miyahara Y, Kageyama S, Ikeda H, Shiku H, Hirano S | ONCOL LETT | 2018 | EPub | https://www.spandidos-publications.com/ol/15/3/3703 | |
| 203 | Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization | Fuchs A et al. | FRONT IMMUNOL | 2018 | EPub | https://www.frontiersin.org/articles/10.3389/fimmu.2017.01844/full | |
| 204 | Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia | Maude SL et al | N ENGL J MED | 2018 | EPub | http://www.nejm.org/doi/full/10.1056/NEJMoa1709866 | |
| 205 | Mycobacterial growth inhibition is associated with trained innate immunity | Joosten SA, van Meijgaarden KE, Arend SM, Prins C, Oftung F, Korsvold GE, Kik SV, Arts RJ, van Crevel R, Netea MG, Ottenhoff TH | J CLIN INVEST | 2018 | EPub | https://www.jci.org/articles/view/97508 | |
| 206 | Dendritic cells as cancer therapeutics | Bryant CE, Sutherland S, Kong B, Papadimitrious MS, Fromm PD, Hart DNJ | SEMIN CELL DEV BIOL | 2018 | EPub | https://www.sciencedirect.com/science/article/pii/S1084952117304950 | |
| 207 | Lenalidomide as immune adjuvant to a dendritic cell vaccine in chronic lymphocytic leukemia patients | Marzia Palma Lotta Hansson Tom A Mulder Lars Adamson Barbro Näsman‐Glaser Ingrid Eriksson Kia Heimersson Fariba Mozaffari Ann Svensson Giusy Gentilcore Anders Österborg Håkan Mellstedt | EUR J HAEMATOL | 2018 | Epub | https://onlinelibrary.wiley.com/doi/abs/10.1111/ejh.13065 | |
| 208 | Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial | Hansje-Eva Teulings et al. | ONCOIMMUNOL | 2018 | Epub | https://www.tandfonline.com/doi/full/10.1080/2162402X.2017.1419113 | |
| 209 | Identification of new MUC1 epitopes using HLA-transgenic animals: implication for immunomonitoring | Tanja Scheikl-Gatard, Caroline Tosch, François Lemonnier, Ronald Rooke | J TRANSL MED | 2017 | EPub | https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-017-1254-0 | |
| 210 | In Vitro Modeling of Tumor–Immune System Interaction | Mengus C et al. | ACS BIOMATER. SCI. ENG. | 2018 | EPub | https://pubs.acs.org/doi/10.1021/acsbiomaterials.7b00077 | |
| 211 | Development of an RNA-based kit for easy generation of TCR-engineered lymphocytes to control T-cell assay performance | Nicole Bidmon, Sonja Kind, Marij J.P. Welters, Deborah JosephPietras, Karoline Laske, Dominik Maurer, Sine Reker Hadrup, Gerty Schreibelt, Richard Rae, Ugur Sahin, Cécile Gouttefangeas, Cedrik M. Britten, Sjoerd H. van der Burg | J IMMUNOL METHODS | 2018 | EPub | https://doi.org/10.1016/j.jim.2018.04.007 | |
| 212 | How measurement science can improve confidence in research results. | Plant, Anne L.; Becker, Chandler A.; Hanisch, Robert J.; Boisvert, Ronald F.; Possolo, Antonio M.; Elliott, John T. | PLOS BIOL | 2018 | EPub | http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.2004299 | |
| 215 | |||||||
| 216 |